Fig. 5
In vitro phagocytosis by isolated human blood neutrophils pre-treated with dasatinib. a MFI values of adherent neutrophils exposed to pHrodo E. coli particles (EC) following pre-treatment with cytochalasin D or dasatinib. b Dose response of dasatinib treatment on neutrophil phagocytosis of autologous serum-opsonized zymosan particles. ***p < 0.001. Values were derived from four experiments, each using neutrophils from different healthy volunteers